Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Industry News

Related Searches:

Filter by:

July 2, 2008
Symbio LLC has opened a new Phase I clinical unit in Michigan City, IN. Symbio provides clinical trial management, biometrics, consulting, product development and topical formulation development. With the addition of the Phase I Unit, the company can…   Read More »
July 1, 2008
Bioanalytical Systems, Inc. (BASi) has sold its Baltimore Clinical Pharmacology Research Unit to a subsidiary of Algorithme Pharma Holdings, Inc. for $850,000 in cash, exiting the Phase I market.     Algorithme, based in Montreal, i…   Read More »
June 30, 2008
Galapagos NV's service division, BioFocus DPI, will provide compound management and related services to Sepracor for a total contract value of $1.5 million. Under the terms of the agreement, BioFocus DPI will receive, register, and store selected com…   Read More »
June 26, 2008
Sanofi Pasteur, the vaccines unit of Sanofi-Aventis, has established a new automated vaccine production facility in Val de Reuil, France to respond to increased vaccine demand worldwide. This new $156 million facility incorporates the latest technolo…   Read More »
June 23, 2008
Penn Pharmaceutical Services U.S. Inc, asubsidiary of UK-based Penn Pharmaceutical Services Ltd., has expanded its clinical trial supplies distribution capabilities with the opening of a 75,000-sq.-ft., temperature-controlled storage and distribution…   Read More »
June 23, 2008
Stiefel Laboratories will acquire Barrier Therapeutics for approximately $148 million. The parties expect the transaction to close by the end of the third quarter of 2008. "This acquisition demonstrates our continued commitment to advancing t…   Read More »
June 20, 2008
Rentschler Biotechnologie has started operation of a 2,500 L multi-process production suite for its bio-CMO operations. The company now has nine stand-alone GMP suites with volumes of 30, 250, 500 and 2,500 liters, allowing the production of material…   Read More »
June 20, 2008
India-based Intas Biopharmaceuticals Ltd. has acquired Biologics Process Development, based in Poway, CA. With the acquisition process underway, both Intas Biopharma and BPD are actively pursuing plans to work closely toward fulfillment of common bus…   Read More »
June 19, 2008
PacificGMP and Pacific Biopharma Group (PBG) have signed a definitive merger agreement and will develop a cGMP biologics CMO in Taizhou, China. At approximately 200,000 sq. ft., the new CMO, called China Quantitative Biomedicine (CQB), will be one of…   Read More »
June 18, 2008
Patheon has selected locations in Research Triangle Park (RTP) and Durham, NC for its global headquarters and new analytical development laboratory facilities. Said Wes Wheeler, chief executive officer and president of Patheon Inc., "Patheon…   Read More »
June 17, 2008
Appian Labs, a biopharmaceutical company specializing in advanced therapeutic design, has launched itself as a company focused on providing comprehensive and strategic drug delivery and design solutions for pharmaceutical and other bioactives compani…   Read More »
June 17, 2008
PharmEng International's wholly owned subsidiary, Keata Pharma Inc., is relocating contract manufacturing operations from its Perth, Ontario facility to their its pharmaceutical manufacturing facility in Sydney, Nova Scotia. Included in the relocatio…   Read More »
June 16, 2008
DSM Biologics and Crucell N.V. have achieved a record yield of more than 27 grams per liter in the production of IgG antibodies using PER.C6 technology. In March 2008 a yield of 15 grams per liter was reported. Higher yields can mean lower production…   Read More »
June 13, 2008
Invitrogen Corp. has agreed to pay $6.4 billion in cash to acquire Applera's Applied Biosystems (AB) Group. AB develops DNA analysis devices for sequencing human genes. Earlier this year, the company announced it had sequenced an entire human genome…   Read More »
June 13, 2008
Parexel International has reached an agreement to acquire ClinPhone, a clinical technology organization headquartered in Nottingham, UK. The acquisition is based on the offer price of approximately $182 million.     Josef von Ricke…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On